- Home
- BNR vs RPAY Comparison
BNR vs RPAY Comparison
Compare BNR & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNR | RPAY |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.2M | 288.0M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BNR | RPAY |
|---|---|---|
| Price | $28.78 | $3.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $6.81 |
| AVG Volume (30 Days) | 11.9K | ★ 927.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $313,042,000.00 |
| Revenue This Year | $136.32 | $0.22 |
| Revenue Next Year | N/A | $6.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.53 |
| 52 Week Low | $2.18 | $2.80 |
| 52 Week High | $41.72 | $7.40 |
Technical Indicators
Market Signals| Indicator | BNR | RPAY |
|---|---|---|
| Relative Strength Index (RSI) | 49.74 | 38.58 |
| Support Level | $28.28 | $2.80 |
| Resistance Level | $34.26 | $3.20 |
| Average True Range (ATR) | 2.86 | 0.17 |
| MACD | -1.00 | -0.02 |
| Stochastic Oscillator | 13.37 | 44.23 |
Price Performance
Historical ComparisonAbout BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.